Rapid sterility is an alternative test method to the US Pharmacopeia (USP) General Chapter <71>, Ph.Eur. 2.6.1, and JP 4.06 sterility tests that allows for shorter incubation periods and faster results. Alcami is launching rapid sterility via the Milliflex® Rapid System, which uses adenosine triphosphate (ATP) bioluminescence for detection of microorganisms after five days. A fully comprehensive comparability study verifies adherence to USP/Ph.Eur. requirements for alternative microbiological methods and demonstrates that rapid sterility is a reliable alternative to the reference method.
In this webinar, Alcami’s rapid sterility expert, Stacey Ramsey, will introduce Alcami’s new rapid sterility platform and provide information for understanding implementation requirements. Stacey will also discuss the advantages of the rapid sterility platform as it compares to USP <71>.
Join us for a webinar to discuss:
- Overall definition of rapid sterility and benefits
- Description of the Milliflex® Rapid System
- Comparison of rapid sterility to USP <71> and harmonized compendial sterility testing
- Description of Alcami’s offering
A Q & A session led by our microbiological experts will follow at the conclusion of the presentation.
Length: 27 Minutes